Positioning and Growth Financing of ELIOS Vision in the Glaucoma Market

Positioning and Growth Financing of ELIOS Vision in the Glaucoma Market

Outcome Capital’s expertise in delivering strategic advisory and investment banking services throughout a client’s life cycle and growth is exemplified by our partnership with ELIOS Vision, a pioneering medical technology company developing next generation of glaucoma treatment. Outcome Capital provided ELIOS Vision with strategic support and investment banking expertise since its inception in early 2019 and played a critical role in the company’s growth and success. Over the past several years, Outcome helped position ELIOS Vision as a key innovator in the $2.5 billion glaucoma treatment market, leading to the company’s recent acquisition by global eye health player Bausch + Lomb.
 

Read the case study:

Download the Case Study